Perspective

Unsere Perspektive

  • Genetic Testing - Why Insurers Must Stay Tuned In

    Von Ross Campbell |March 22, 2015|English

    Genomics is at the forefront of a technological revolution in biomedicine and healthcare through which personalised treatment is fast becoming a reality. Genomics will improve care across a range of health problems and allow more targeted therapy. If...

    Lesen Sie mehr
  • Thyroid Cancer - Critical Threat?

    Von Ross Campbell |February 03, 2015|English

    Being told of the first sign of a cancer with deadly potential, but which early treatment may cure, is a medical reassurance anyone would be relieved to receive. The benefit of detection is less clear when the detected “cancer” is most likely...

    Lesen Sie mehr
  • Diabetes and Life Insurance - Crossing the Divide

    Von Andres Webersinke |November 13, 2014|English

    Diabetes is on track to become the world’s seventh leading cause of death by 2030, according to the World Health Organization. Diabetes already affects several hundred million people and worryingly, younger people are increasingly being diagnosed...

    Lesen Sie mehr
  • DIY Genetic Testing - Is the Genie Out of the Bottle?

    Von Dr. John Cummins|August 19, 2014|English

    The first sequence of the human genome was made publicly available in 2003. It took international laboratories collaborating over 10 years to complete, at a cost of around US$3 billion. Technological advances now mean that a human genome can be sequenced...

    Lesen Sie mehr
  • Screening and Overdiagnosis - Better the Devil You Know?

    Von Dr. Ian Cox|August 17, 2014|English

    New technologies and therapies in medicine have hugely improved the early diagnosis and treatment of many conditions. But, it’s becoming clear that these advances come with a cost. A significant number of people are now being told they have a...

    Lesen Sie mehr
  • Life Benefit Riders – Get on Track

    Von Joe Atamaniuk|June 19, 2014|English

    Living benefit riders, or accelerated death benefit riders (ABR), have been around the life insurance arena for many years, but as the industry looks for ways to attract new customers, their use has intensified recently. There are three different kinds...

    Lesen Sie mehr